SANOCHEMIA Pharmazeutika Overview
- Founded
- 1994
- Status
- Public
- Employees
- 120
- Stock Symbol
- SAC
- Investments
- 2
- Share Price
- $0.07
- (As of Friday Closing)
SANOCHEMIA Pharmazeutika General Information
Description
Sanochemia Pharmazeutika AG is a specialty pharmaceuticals company. It focused on the development and manufacture of novel drugs and diagnostics in selected indication areas which includes neurodegeneration, pain, and oncology, as well as diagnostics based on contrast media. The products of the company address the unmet medical need and offer the potential for significant returns. Its business divisions are Active pharmaceutical ingredients which are engaged in the development and production of new active pharmaceutical ingredients ranging from establishing laboratory processes through up-scaling to industrial-scale production; Pharmaceutical production which manufactures sterile and semi-sterile liquid presentations; Clinical Diagnostics and Veterinary Pharmaceuticals.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
DUS
Primary Office
- Landeggerstrasse 7 and 33
- Neufeld an der Leitha, Burgenland 2491
- Austria
+43 02624 00000000
SANOCHEMIA Pharmazeutika Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.07 | $0.07 | $0.04 - $2.27 | $1.26M | 15.6M | 313.49 | -$1.44 |
SANOCHEMIA Pharmazeutika Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2019 | FY 2018 30-Sep-2018 | FY 2017 30-Sep-2017 | FY 2016 30-Sep-2016 |
|---|---|---|---|---|
| EV | 44,570 | 42,047 | 42,136 | 35,066 |
| Revenue | 38,580 | 39,289 | 45,630 | 43,660 |
| EBITDA | (10,052) | (6,244) | 3,987 | 3,484 |
| Net Income | (19,048) | (15,795) | (278) | (617) |
| Total Assets | 77,278 | 79,545 | 88,261 | 87,147 |
| Total Debt | 19,271 | 20,731 | 18,453 | 20,712 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
SANOCHEMIA Pharmazeutika Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore SANOCHEMIA Pharmazeutika‘s full profile, request access.
Request a free trialSANOCHEMIA Pharmazeutika Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Johann Roither | Chief Executive Officer | ||
| Timo Bender | Co-Managing Director | ||
| Thomas Erkinger | Co-Managing Director |
SANOCHEMIA Pharmazeutika Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSANOCHEMIA Pharmazeutika Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore SANOCHEMIA Pharmazeutika‘s full profile, request access.
Request a free trialSANOCHEMIA Pharmazeutika Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 & 000000 | 21-Sep-2011 | 000000000000000000 | 00.000 | Other Pharmaceuticals and Biotechnology | |
| AlcaSynn Pharmaceuticals | 09-Jun-2006 | Merger/Acquisition | 000.00 | Drug Discovery |
SANOCHEMIA Pharmazeutika Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 0000000 & 000000 | Other Pharmaceuticals and Biotechnology | Vienna, Austria | 0000 |